Stockscreener 앱 받기
0.5959
7.91%
-0.0512
Envoy Medical Inc 주식(COCH)의 최신 뉴스
Envoy Medical announces 1-for-10 reverse stock split By Investing.com - Investing.com UK
Envoy Medical Announces Reverse Stock Split - Yahoo Finance
A 1-for-10 split is intended to help Envoy Medical meet Nasdaq’s $1 minimum bid requirement. - Stock Titan
Envoy Medical Hits Six-Month Milestone, Marks Halfway Point in Final Stage of Data Collection, and Highlights Differentiated Device Design - TMX Newsfile
A surgeon joining P3 Health Partners gets an option to buy 110,000 shares. - Stock Titan
Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear Implant - www.marketscreener.com
Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio - TMX Newsfile
Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio - Yahoo Finance
A hearing-device maker adds two patents, bringing its global total to 97 - Stock Titan
Alta Partners reports 2.1M Envoy Medical (COCH) shares - stocktitan.net
Enterprise value to EBIT forward of Envoy Medical, Inc. – NASDAQ:COCHW - TradingView
COCH News | ENVOY MEDICAL INC (NASDAQ:COCH) - ChartMill
Price to earnings forward of Envoy Medical, Inc. – NASDAQ:COCHW - TradingView
Envoy Medical CEO to present fully implanted he... - Pluang
Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th - Yahoo Finance
Envoy Medical CEO to Present at H.C. Wainwright 28th Annual Global Investment Conference in September 2026 - kalkine.ca
Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th - TMX Newsfile
Envoy Medical Inc. (NASDAQ: COCH) Share Price, COCH Stock News, COCH Share Price & Updates - kalkine.ca
Envoy Medical (NASDAQ: COCH) weighs 1‑for‑25 reverse split to avoid delisting - Stock Titan
Envoy Medical Inc (COCH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Envoy Medical names Robert Potashnick Chief Accounting Officer and VP of Finance - TradingView
Envoy Medical (COCH) awards 250K options to Potashnick - stocktitan.net
Are Medical Stocks Lagging Compugen (CGEN) This Year? - Yahoo Finance
HC Wainwright Cuts Envoy Medical (NASDAQ:COCH) Price Target to $2.00 - MarketBeat
H.C. Wainwright cuts Envoy Medical stock price target on share count - Investing.com Canada
H.C. Wainwright cuts Envoy Medical stock price target on share count - Investing.com UK
COCH Maintained by HC Wainwright & Co. -- Price Target Lowered t - GuruFocus
Envoy (COCH) Earnings Report: Profit Per Share Surpasses Its Benchmark in the Current Update; Price Move - vinanet.vn
Envoy (COCH) Q1 2026 Earnings: The Bottom-Line Figure Beats Its Comparison for the Current Session - vinanet.vn
Envoy (COCHW) Momentum: Trades in a Narrow Directional Range at $0.05 at the Close - vinanet.vn
Envoy Medical Warrant (COCHW) Holds at $0.05 as Flat Trading PersistsBullish Percent Index - Vinanet
Envoy Medical Warrant (COCHW) Holds at $0.05 as Flat Trading PersistsVolume Breakout Ideas - dars.gov.et
Price to sales forward of Envoy Medical, Inc. – NASDAQ:COCH - TradingView
Price to earnings forward of Envoy Medical, Inc. – NASDAQ:COCH - TradingView
New to The Street Its The Platformsinvestor distribution. - ACCESS Newswire
New to The Street Airs This Weekend Across Bloomberg Television U.S., Latin America and MENA - Caledonian Record
The Beat: Target names AI chief, Niron gets White House backing, Envoy chases cochlear market - The Business Journals
Envoy Medical’s Limited Disclosures Put Spotlight on 10-K Risk Factors for Investors - TipRanks
Envoy Medical earnings beat, revenue fell short of estimates By Investing.com - Investing.com Canada
Envoy Medical earnings beat, revenue fell short of estimates - Investing.com
Envoy Medical (NASDAQ: COCH) raises cash, advances fully implanted cochlear implant - Stock Titan
Envoy Medical Releases Q2 2026 Financial Results - AlphaStreet
Envoy Medical, Inc. (COCH) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Envoy Medical (NASDAQ:COCH) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS - MarketBeat
Envoy Medical Q2 Results: EPS beats estimate, sales miss - scanx.trade
Envoy Medical, Inc. Q2 2026: Revenue $51K, Net loss $5982K — 10-Q Summary - TradingView
Envoy Medical (NASDAQ: COCH) burns cash on Acclaim implant trial after $28M raise - Stock Titan
Price to book forward of Envoy Medical, Inc. – NASDAQ:COCHW - TradingView
Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones - newsfilecorp.com
Envoy Medical (COCH) Reports Q2 2026 Results, Submits First FDA PMA Module and Posts Strong Acclaim® Cochlear Implant Clinical Data - kalkine.ca
6.48%
0.35%
자본화:
|
볼륨(24시간):